发明名称 |
Stabilized liquid and lyophilized adamts13 formulations |
摘要 |
<p>598839 Disclosed is a stabilized formulation of ADAMTS 13 for lyophilization, comprising: (a) 0.05 mg/ml to 10.0 mg/ml ADAMTS13; (b) less than 100 mM of a pharmaceutically acceptable salt; (c) 0.5 mM to 20 mM calcium; (d) a sugar and/or sugar alcohol; (e) a nonionic surfactant; and (f) a buffering agent for maintaining a pH between 6.0 and 8.0.</p> |
申请公布号 |
NZ598839(A) |
申请公布日期 |
2014.03.28 |
申请号 |
NZ20100598839 |
申请日期 |
2010.09.21 |
申请人 |
BAXTER INTERNATIONAL INC.;BAXTER HEALTHCARE S.A. |
发明人 |
SCHWARZ HANS-PETER;MATTHIESSEN H. PETER;TURECEK PETER L. |
分类号 |
A61K9/00;A61K9/10;A61K38/43;A61K38/48 |
主分类号 |
A61K9/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|